Lysophosphatidic Acid Antibody (504B3)

Produktübersicht

• Artikelname: Lysophosphatidic Acid Antibody (504B3)
• Artikelnummer: ECH-Z-P200
• Hersteller Artikelnummer: Z-P200
• Alternativnummer: ECH-Z-P200-10UG, ECH-Z-P200-250UG, ECH-Z-P200-50UG
• Hersteller: Echelon Biosciences
• Kategorie: Molekularbiologie

Produktbeschreibung

Purified Anti-Lysophosphatidic Acid (LPA) monoclonal antibody. Subclass: IgGk1 Source: Mouse Applications: ELISA, Immunohistochemistry, Immunocytochemistry

---

Product Background: Lysophosphatidic Acid (LPA) is a serum-derived phospholipid involved in diverse ceullular processes such as cell proliferation, chemotaxis, platelet aggregation, wound healing, angiogensis, tumor invasion, and smooth muscle contraction. Recent research indicates LPA may play a significant role in the pathophysiology of cancer and may be used as a biomarker for ovarian cancer. The Lysophosphatidic Acid Antibody (504B3) was originally developed and patented at Lpath Therapeutics.

Storage

Antibody is stable for up to 1 year at -20 C. Antibody is stable for 60 days at 4C. Avoid repeated freeze/thaw cycles.

References

1) J. Cheng, S. Sahani, T.J. Hausrat, et al. (2016) Precise Somatotopic Thalamocortical Axon Guidance Depends on LPA-Mediated PRG-2/Radixin Signaling Neuron, 92(1), 126-142. doi: doi:10.1016/j.neuron.2016.08.035 2) M. Balood, H. Zahednasab, et al. (2014) Elevated serum levels of lysophosphatidic acid in patients with multiple sclerosis Hum. Immunol. 75(5), 411-413, doi: 10.1016/j.humimm.2014.02.021 3) Y. Goldshmit, R. Matteo, et al. (2012) Blockage of lysophosphatidic acid signaling improves spinal cord injury outcomes. Am. J. Pathol. , 181(3): 978-992, doi: 10.1016/j.ajpath.2012.06.007 Bulk discounts available, please email echelon echelon-inc.com for information.

---

Documents

Technical Data Sheet

Anwendungsbeschreibung

• Anwendungsbeschreibung: Categories: Antibodies & Proteins. Related: Antibody, Lipid Binding, Lysophosphatidic Acid. Ship 1 : Shipping Temp. Ship 2: Dry Ice